Decreased antimony uptake and overexpression of genes of thiol metabolism are associated with drug resistance in a canine isolate of Leishmania infantum

Visceral leishmaniasis (VL) caused by the protozoan parasite Leishmania infantum, is one of the most important zoonotic diseases affecting dogs and humans in the Mediterranean area. The presence of infected dogs as the main reservoir host of L. infantum is regarded as the most significant risk for p...

Full description

Bibliographic Details
Main Authors: Verónica Gómez Pérez, Raquel García-Hernandez, Victoriano Corpas-López, Ana M. Tomás, Joaquina Martín-Sanchez, Santiago Castanys, Francisco Gamarro
Format: Article
Language:English
Published: Elsevier 2016-08-01
Series:International Journal for Parasitology: Drugs and Drug Resistance
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2211320716300070
_version_ 1818445651000688640
author Verónica Gómez Pérez
Raquel García-Hernandez
Victoriano Corpas-López
Ana M. Tomás
Joaquina Martín-Sanchez
Santiago Castanys
Francisco Gamarro
author_facet Verónica Gómez Pérez
Raquel García-Hernandez
Victoriano Corpas-López
Ana M. Tomás
Joaquina Martín-Sanchez
Santiago Castanys
Francisco Gamarro
author_sort Verónica Gómez Pérez
collection DOAJ
description Visceral leishmaniasis (VL) caused by the protozoan parasite Leishmania infantum, is one of the most important zoonotic diseases affecting dogs and humans in the Mediterranean area. The presence of infected dogs as the main reservoir host of L. infantum is regarded as the most significant risk for potential human infection. We have studied the susceptibility profile to antimony and other anti-leishmania drugs (amphotericin B, miltefosine, paromomycin) in Leishmania infantum isolates extracted from a dog before and after two therapeutic interventions with meglumine antimoniate (subcutaneous Glucantime®, 100 mg/kg/day for 28 days). After the therapeutic intervention, these parasites were significantly less susceptible to antimony than pretreatment isolate, presenting a resistance index of 6-fold to SbIII for promastigotes and >3-fold to SbIII and 3-fold to SbV for intracellular amastigotes. The susceptibility profile of this resistant L. infantum line is related to a decreased antimony uptake due to lower aquaglyceroporin-1 expression levels. Additionally, other mechanisms including an increase in thiols and overexpression of enzymes involved in thiol metabolism, such as ornithine decarboxylase, trypanothione reductase, mitochondrial tryparedoxin and mitochondrial tryparedoxin peroxidase, could contribute to the resistance as antimony detoxification mechanisms. A major contribution of this study in a canine L. infantum isolate is to find an antimony-resistant mechanism similar to that previously described in other human clinical isolates.
first_indexed 2024-12-14T19:35:13Z
format Article
id doaj.art-804426a8f78a44c69810870a8bd33090
institution Directory Open Access Journal
issn 2211-3207
language English
last_indexed 2024-12-14T19:35:13Z
publishDate 2016-08-01
publisher Elsevier
record_format Article
series International Journal for Parasitology: Drugs and Drug Resistance
spelling doaj.art-804426a8f78a44c69810870a8bd330902022-12-21T22:49:55ZengElsevierInternational Journal for Parasitology: Drugs and Drug Resistance2211-32072016-08-016213313910.1016/j.ijpddr.2016.04.003Decreased antimony uptake and overexpression of genes of thiol metabolism are associated with drug resistance in a canine isolate of Leishmania infantumVerónica Gómez Pérez0Raquel García-Hernandez1Victoriano Corpas-López2Ana M. Tomás3Joaquina Martín-Sanchez4Santiago Castanys5Francisco Gamarro6Instituto de Parasitología y Biomedicina “López-Neyra”, CSIC, (IPBLN-CSIC), Parque Tecnológico de Ciencias de la Salud, Granada, SpainInstituto de Parasitología y Biomedicina “López-Neyra”, CSIC, (IPBLN-CSIC), Parque Tecnológico de Ciencias de la Salud, Granada, SpainDepartamento de Parasitología, Facultad de Farmacia, Universidad de Granada, Granada, SpainIBMC – Institute for Molecular and Cell Biology, Porto, PortugalDepartamento de Parasitología, Facultad de Farmacia, Universidad de Granada, Granada, SpainInstituto de Parasitología y Biomedicina “López-Neyra”, CSIC, (IPBLN-CSIC), Parque Tecnológico de Ciencias de la Salud, Granada, SpainInstituto de Parasitología y Biomedicina “López-Neyra”, CSIC, (IPBLN-CSIC), Parque Tecnológico de Ciencias de la Salud, Granada, SpainVisceral leishmaniasis (VL) caused by the protozoan parasite Leishmania infantum, is one of the most important zoonotic diseases affecting dogs and humans in the Mediterranean area. The presence of infected dogs as the main reservoir host of L. infantum is regarded as the most significant risk for potential human infection. We have studied the susceptibility profile to antimony and other anti-leishmania drugs (amphotericin B, miltefosine, paromomycin) in Leishmania infantum isolates extracted from a dog before and after two therapeutic interventions with meglumine antimoniate (subcutaneous Glucantime®, 100 mg/kg/day for 28 days). After the therapeutic intervention, these parasites were significantly less susceptible to antimony than pretreatment isolate, presenting a resistance index of 6-fold to SbIII for promastigotes and >3-fold to SbIII and 3-fold to SbV for intracellular amastigotes. The susceptibility profile of this resistant L. infantum line is related to a decreased antimony uptake due to lower aquaglyceroporin-1 expression levels. Additionally, other mechanisms including an increase in thiols and overexpression of enzymes involved in thiol metabolism, such as ornithine decarboxylase, trypanothione reductase, mitochondrial tryparedoxin and mitochondrial tryparedoxin peroxidase, could contribute to the resistance as antimony detoxification mechanisms. A major contribution of this study in a canine L. infantum isolate is to find an antimony-resistant mechanism similar to that previously described in other human clinical isolates.http://www.sciencedirect.com/science/article/pii/S2211320716300070LeishmaniaCanine leishmaniasisTherapeutic failureAntimony resistanceAntimony uptakeAquaglyceroporinThiolsPeroxiredoxins
spellingShingle Verónica Gómez Pérez
Raquel García-Hernandez
Victoriano Corpas-López
Ana M. Tomás
Joaquina Martín-Sanchez
Santiago Castanys
Francisco Gamarro
Decreased antimony uptake and overexpression of genes of thiol metabolism are associated with drug resistance in a canine isolate of Leishmania infantum
International Journal for Parasitology: Drugs and Drug Resistance
Leishmania
Canine leishmaniasis
Therapeutic failure
Antimony resistance
Antimony uptake
Aquaglyceroporin
Thiols
Peroxiredoxins
title Decreased antimony uptake and overexpression of genes of thiol metabolism are associated with drug resistance in a canine isolate of Leishmania infantum
title_full Decreased antimony uptake and overexpression of genes of thiol metabolism are associated with drug resistance in a canine isolate of Leishmania infantum
title_fullStr Decreased antimony uptake and overexpression of genes of thiol metabolism are associated with drug resistance in a canine isolate of Leishmania infantum
title_full_unstemmed Decreased antimony uptake and overexpression of genes of thiol metabolism are associated with drug resistance in a canine isolate of Leishmania infantum
title_short Decreased antimony uptake and overexpression of genes of thiol metabolism are associated with drug resistance in a canine isolate of Leishmania infantum
title_sort decreased antimony uptake and overexpression of genes of thiol metabolism are associated with drug resistance in a canine isolate of leishmania infantum
topic Leishmania
Canine leishmaniasis
Therapeutic failure
Antimony resistance
Antimony uptake
Aquaglyceroporin
Thiols
Peroxiredoxins
url http://www.sciencedirect.com/science/article/pii/S2211320716300070
work_keys_str_mv AT veronicagomezperez decreasedantimonyuptakeandoverexpressionofgenesofthiolmetabolismareassociatedwithdrugresistanceinacanineisolateofleishmaniainfantum
AT raquelgarciahernandez decreasedantimonyuptakeandoverexpressionofgenesofthiolmetabolismareassociatedwithdrugresistanceinacanineisolateofleishmaniainfantum
AT victorianocorpaslopez decreasedantimonyuptakeandoverexpressionofgenesofthiolmetabolismareassociatedwithdrugresistanceinacanineisolateofleishmaniainfantum
AT anamtomas decreasedantimonyuptakeandoverexpressionofgenesofthiolmetabolismareassociatedwithdrugresistanceinacanineisolateofleishmaniainfantum
AT joaquinamartinsanchez decreasedantimonyuptakeandoverexpressionofgenesofthiolmetabolismareassociatedwithdrugresistanceinacanineisolateofleishmaniainfantum
AT santiagocastanys decreasedantimonyuptakeandoverexpressionofgenesofthiolmetabolismareassociatedwithdrugresistanceinacanineisolateofleishmaniainfantum
AT franciscogamarro decreasedantimonyuptakeandoverexpressionofgenesofthiolmetabolismareassociatedwithdrugresistanceinacanineisolateofleishmaniainfantum